Skip to main content
. 2016 Feb 25;1(2):e84897. doi: 10.1172/jci.insight.84897

Figure 1. Increased lysine acetylation of mitochondrial proteins involved in multiple mitochondrial energy transduction pathways in cardiac tissue of mice from the heart failure group.

Figure 1

(A) Lysine-acetylated proteins (indicated by circles, protein symbols are noted) identified by mass spectrometry in both heart failure (HF) samples and sham-operated control samples (n = 2/group) in each of the 3 main mitochondrial fuel oxidation/ATP synthesis pathways (β-oxidation, tricarboxylic acid [TCA] cycle, and electron transport complex [ETC]). All acetylated residues with at least ± 1.5 fold change for mean HF/control values are shown. Specific lysine acetylation sites are noted in parentheses. Acetylation status is indicated by color coding: proteins with increased acetylation (HF/sham) are in red; proteins with decreased acetylation are in blue; and proteins with no change are in gray. (B) All detected acetylated mitochondrial proteins were rank ordered according to log2 fold change between compensated hypertrophy (CH) or HF and their corresponding sham controls in mean protein abundance along the x axis (blue circles). The log2 fold change between CH or HF and corresponding sham controls of each detected acetyl isoform (red squares, normalized to corresponding protein abundance) is plotted on the y axis in the same position on the x axis as the corresponding protein. The dashed line represents no change in acetylation level. Additional numerical data is provided in Supplemental Tables 2-4. SDHA, succinate dehydrogenase A.